Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease

go back to reference Civeira F, Pocoví M, Alegría E, Alonso R, Carmena R, Casasnovas JA, Defesche JC, Jensen HK, Hopkins PN, Illingworth DR, Luengo E, Masana L, Mata P, Pérez-Jiménez F, Schaefer EJ, Thompson GR (2004) Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173:55–68CrossRef Civeira F, Pocoví M, Alegría E, Alonso R, Carmena R, Casasnovas JA, Defesche JC, Jensen HK, Hopkins PN, Illingworth DR, Luengo E, Masana L, Mata P, Pérez-Jiménez F, Schaefer EJ, Thompson GR (2004) Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173:55–68CrossRef

go back to reference Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M (2017) Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J 38:1573–1579CrossRef Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M (2017) Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Eur Heart J 38:1573–1579CrossRef

go back to reference Schmidt HHJ, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM (1996) Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 77:575–580CrossRef Schmidt HHJ, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM (1996) Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 77:575–580CrossRef

go back to reference Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJG (2009) Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 207:311–317CrossRef Oosterveer DM, Versmissen J, Yazdanpanah M, Hamza TH, Sijbrands EJG (2009) Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: a systematic review and meta-analysis. Atherosclerosis 207:311–317CrossRef

go back to reference Hashimoto T, Minami Y, Kakizaki R, Nemoto T, Fujiyoshi K, Meguro K, Shimohama T, Tojo T, Ako J (2019) Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease. J Clin Lipidol 13:194–200CrossRef Hashimoto T, Minami Y, Kakizaki R, Nemoto T, Fujiyoshi K, Meguro K, Shimohama T, Tojo T, Ako J (2019) Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease. J Clin Lipidol 13:194–200CrossRef

go back to reference Mabuchi H, Ito S, Haba T, Ueda K, Ueda R, Koizumi J, Ohta M, Miyamoto S, Takeda R, Tatami R, Kametani T, Takegoshi T (1977) Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. Atherosclerosis 28:61–68CrossRef Mabuchi H, Ito S, Haba T, Ueda K, Ueda R, Koizumi J, Ohta M, Miyamoto S, Takeda R, Tatami R, Kametani T, Takegoshi T (1977) Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness. Atherosclerosis 28:61–68CrossRef

go back to reference Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Okamura T, Ninomiya T, Hozawa A, Yokode M, Iida M, Hasegawa K, Hara M, Yamato H, Shoji T, Abe T, Egusa G, Emoto M, Kashihara N, Saiki A, Tomiyama H, Hashimoto JI, Hosomi N, Yamazaki Y, Bujo H, Inoue I, Inoue S, Koba S, Sawada S, Sone H, Fujioka Y, Hiro S, Funabashi T, Maruyama C, Matsumoto M, Ohtsuki T, Kitagawa K, Kitazono T, Terayama Y, Tomimoto H, Toyoda K, Harada-Shiba M, Arai H, Ishibashi S, Nohara A, Ohta T, Ogura M, Ohtake A, Yokote K (2018) Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25:846–984CrossRef Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Okamura T, Ninomiya T, Hozawa A, Yokode M, Iida M, Hasegawa K, Hara M, Yamato H, Shoji T, Abe T, Egusa G, Emoto M, Kashihara N, Saiki A, Tomiyama H, Hashimoto JI, Hosomi N, Yamazaki Y, Bujo H, Inoue I, Inoue S, Koba S, Sawada S, Sone H, Fujioka Y, Hiro S, Funabashi T, Maruyama C, Matsumoto M, Ohtsuki T, Kitagawa K, Kitazono T, Terayama Y, Tomimoto H, Toyoda K, Harada-Shiba M, Arai H, Ishibashi S, Nohara A, Ohta T, Ogura M, Ohtake A, Yokote K (2018) Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb 25:846–984CrossRef

go back to reference Catapano AL, Lautsch D, Tokgözoglu L, Ferrieres J, Horack M, Farnier M, Toth PP, Brudi P, Tomassini JE, Ambegaonkar B, Gitt AK (2016) Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice. Atherosclerosis 252:1–8CrossRef Catapano AL, Lautsch D, Tokgözoglu L, Ferrieres J, Horack M, Farnier M, Toth PP, Brudi P, Tomassini JE, Ambegaonkar B, Gitt AK (2016) Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice. Atherosclerosis 252:1–8CrossRef

go back to reference Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson W, Yancy CW (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol 58:e44–e122CrossRef Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson W, Yancy CW (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol 58:e44–e122CrossRef

go back to reference Hirobe K, Matsuzawa Y, Ishikawa K, Tarui S, Yamamoto A, Nambu S, Fujimoto K (1982) Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 44:201–210CrossRef Hirobe K, Matsuzawa Y, Ishikawa K, Tarui S, Yamamoto A, Nambu S, Fujimoto K (1982) Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 44:201–210CrossRef

go back to reference Mangili LC, Miname MH, Silva PRS, Bittencourt MS, Rocha VZ, Mangili OC, Salgado Filho W, Chacra AP, Jannes CE, Pereira AC, Santos RD (2017) Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: a pilot study. Atherosclerosis 263:393–397CrossRef Mangili LC, Miname MH, Silva PRS, Bittencourt MS, Rocha VZ, Mangili OC, Salgado Filho W, Chacra AP, Jannes CE, Pereira AC, Santos RD (2017) Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: a pilot study. Atherosclerosis 263:393–397CrossRef

go back to reference Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y (2020) Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention. J Cardiol 75:654–658CrossRef Kitahara H, Nakayama T, Fujimoto Y, Kobayashi Y (2020) Association between Achilles tendon xanthoma and severity of coronary artery disease in patients undergoing percutaneous coronary intervention. J Cardiol 75:654–658CrossRef

go back to reference Uemura S, Ishigami KI, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y (2012) Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 33:78–85CrossRef Uemura S, Ishigami KI, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y (2012) Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J 33:78–85CrossRef

go back to reference Komukai K, Kubo T, Kitabata H, Matsuo Y, Ozaki Y, Takarada S, Okumoto Y, Shiono Y, Orii M, Shimamura K, Ueno S, Yamano T, Tanimoto T, Ino Y, Yamaguchi T, Kumiko H, Tanaka A, Imanishi T, Akagi H, Akasaka T (2014) Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study. J Am Coll Cardiol 64:2207–2217CrossRef Komukai K, Kubo T, Kitabata H, Matsuo Y, Ozaki Y, Takarada S, Okumoto Y, Shiono Y, Orii M, Shimamura K, Ueno S, Yamano T, Tanimoto T, Ino Y, Yamaguchi T, Kumiko H, Tanaka A, Imanishi T, Akagi H, Akasaka T (2014) Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study. J Am Coll Cardiol 64:2207–2217CrossRef

go back to reference Bryniarski KL, Tahk SJ, Choi SY, Soeda T, Higuma T, Yamamoto E, Xing L, Dai J, Zanchin T, Lee H, Jang IK (2017) Clinical, angiographic, IVUS, and OCT predictors for irregular protrusion after coronary stenting. EuroIntervention 12:e2204–e2211CrossRef Bryniarski KL, Tahk SJ, Choi SY, Soeda T, Higuma T, Yamamoto E, Xing L, Dai J, Zanchin T, Lee H, Jang IK (2017) Clinical, angiographic, IVUS, and OCT predictors for irregular protrusion after coronary stenting. EuroIntervention 12:e2204–e2211CrossRef

go back to reference Hoshino M, Yonetsu T, Kanaji Y, Usui E, Yamaguchi M, Hada M, Hamaya R, Kanno Y, Murai T, Lee T, Kakuta T (2019) Impact of baseline plaque characteristic on the development of neoatherosclerosis in the very late phase after stenting. J Cardiol 74:67–73CrossRef Hoshino M, Yonetsu T, Kanaji Y, Usui E, Yamaguchi M, Hada M, Hamaya R, Kanno Y, Murai T, Lee T, Kakuta T (2019) Impact of baseline plaque characteristic on the development of neoatherosclerosis in the very late phase after stenting. J Cardiol 74:67–73CrossRef

go back to reference Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, Mueller C, Drexel H, Aboyans V, Corsini A, Doehner W, Farnier M, Gigante B, Kayikcioglu M, Krstacic G, Lambrinou E, Lewis BS, Masip J, Moulin P, Petersen S, Petronio AS, Piepoli MF, Pinto X, Raber L, Ray KK, Reiner Z, Riesen WF, Roffi M, Schmid JP, Shlyakhto E, Simpson IA, Stroes E, Sudano I, Tselepis AD, Viigimaa M, Vindis C, Vonbank A, Vrablik M, Vrsalovic M, Gomez JLZ, Collet JP, Windecker S, Dean V, Fitzsimons D, Gale CP, Grobbee DE, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus HA, Leclercq C, Lettino M, Merkely B, Sousa-Uva M, Touyz RM, Nibouche D, Zelveian PH, Siostrzonek P, Najafov R, Van De Borne P, Pojskic B, Postadzhiyan A, Kypris L, Spinar J, Larsen ML, Eldin HS, Strandberg TE, Ferrières J, Agladze R, Laufs U, Rallidis L, Bajnok L, Gudjonsson T, Maher V, Henkin Y, Gulizia MM, Mussagaliyeva A, Bajraktari G, Kerimkulova A, Latkovskis G, Hamoui O, Slapikas R, Visser L, Dingli P, Ivanov V, Boskovic A, Nazzi M, Visseren F, Mitevska I, Retterstøl K, Jankowski P, Fontes-Carvalho R, Gaita D, Ezhov M, Foscoli M, Giga V, Pella D, Fras Z, de Isla LP, Hagström E, Lehmann R, Abid L, Ozdogan O, Mitchenko O, Patel RS (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111–188CrossRef Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, Mueller C, Drexel H, Aboyans V, Corsini A, Doehner W, Farnier M, Gigante B, Kayikcioglu M, Krstacic G, Lambrinou E, Lewis BS, Masip J, Moulin P, Petersen S, Petronio AS, Piepoli MF, Pinto X, Raber L, Ray KK, Reiner Z, Riesen WF, Roffi M, Schmid JP, Shlyakhto E, Simpson IA, Stroes E, Sudano I, Tselepis AD, Viigimaa M, Vindis C, Vonbank A, Vrablik M, Vrsalovic M, Gomez JLZ, Collet JP, Windecker S, Dean V, Fitzsimons D, Gale CP, Grobbee DE, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus HA, Leclercq C, Lettino M, Merkely B, Sousa-Uva M, Touyz RM, Nibouche D, Zelveian PH, Siostrzonek P, Najafov R, Van De Borne P, Pojskic B, Postadzhiyan A, Kypris L, Spinar J, Larsen ML, Eldin HS, Strandberg TE, Ferrières J, Agladze R, Laufs U, Rallidis L, Bajnok L, Gudjonsson T, Maher V, Henkin Y, Gulizia MM, Mussagaliyeva A, Bajraktari G, Kerimkulova A, Latkovskis G, Hamoui O, Slapikas R, Visser L, Dingli P, Ivanov V, Boskovic A, Nazzi M, Visseren F, Mitevska I, Retterstøl K, Jankowski P, Fontes-Carvalho R, Gaita D, Ezhov M, Foscoli M, Giga V, Pella D, Fras Z, de Isla LP, Hagström E, Lehmann R, Abid L, Ozdogan O, Mitchenko O, Patel RS (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111–188CrossRef